Financial Disclosure Omitted: In the Preliminary
Communication entitled “Diagnosis of Intra-amniotic Infection by Proteomic
Profiling and Identification of Novel Biomarkers” published in the July
28, 2004, issue of JAMA (2004;292:462-469), a financial
disclosure was omitted. Oregon Health and Science University (OHSU), Drs Gravett,
Rosenfeld, Reddy, Jacob, Roberts, and Nagalla and Mr Turner all have a significant
financial interest in Proteogenix Inc, a company that may have a commercial
interest in the results of this research and technology. Among the 3 investigators
involved in statistical analysis of the study (Drs Gravett, Lapidus, and Hitti),
the latter 2 have no potential financial interest in the results of this research.
This potential conflict of interest has been reviewed and a management plan
approved by the OHSU Conflict of Interest in Research Committee, and the Integrity
Program Oversight Council has been implemented.
Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers. JAMA. 2004;292(19):2340. doi:10.1001/jama.292.19.2340